|Mr. David Attard||CEO & Director||92.61k||N/A||1973|
|Mr. Scott Laitinen||Chief Financial Officer||475.93k||N/A||1964|
|Mr. David Gordon||Chief Corp. Officer||125.41k||N/A||1964|
|Mr. Anthony W. Wile||Special Consultant||273.84k||N/A||N/A|
|Mr. Henning von Koss||Pres & Director||N/A||N/A||1962|
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis oil extracts, tetrahydrocannabinol, and related products to pharmacies, medical clinics, and cosmetic companies. The company also offers telemedicine software. It serves in Canada, Colombia, Italy, and Mexico. PharmaCielo Ltd. is headquartered in Toronto, Canada.
PharmaCielo Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.